- Home
- A-Z Publications
- Current Drug Metabolism
- Previous Issues
- Volume 16, Issue 3, 2015
Current Drug Metabolism - Volume 16, Issue 3, 2015
Volume 16, Issue 3, 2015
-
-
Myeloperoxidase Inhibitors as Potential Drugs
Authors: Tamara Lazarevic-Pasti, Andreja Leskovac and Vesna VasicMyeloperoxidase (MPO) is an important member of the haem peroxidase - cyclooxygenase superfamily. This enzyme is physiologically expressed in circulating neutrophils, monocytes and some tissue macrophages including microglia. MPO plays an essential role in the antimicrobial and antiviral system of humans. The microbicidal activity of MPO exists due to its capability to oxidize halide and pseudohalide ions (CI-, Br-, I- and SC Read More
-
-
-
Applications of Metabonomics in Pesticide Toxicology
More LessMetabonomic studies quantitatively measure the small molecule metabolites and their intermediates in the biological samples (serum, urine or tissue extracts) and have gained wide applications in many fields, especially in toxicology. Pesticides are extensively used around the world and pesticide toxicity has become a serious threat to human health. Metabonomic approach has been applied in many aspects of pesticide t Read More
-
-
-
Lipid-Based Formulations for Oral Drug Delivery: Effects on Drug Absorption and Metabolism
Authors: Quanlei Zhu, Xiuying Li, Dengning Xia, Hongzhen Yu, Dan Chen, Weiwei Fan and Yong GanThe application of lipid-based drug delivery systems on the industrial scale has successfully demonstrated their therapeutic and manufacturing advantages. Recently, various lipid-based formulations were successfully prepared for oral delivery of compounds that are difficult to administer. Nevertheless, an improved understanding of how these formulations affect drug absorption and metabolism is required to support the r Read More
-
-
-
Submicron Lipid Emulsions: A Versatile Platform for Drug Delivery
Authors: Xingwang Zhang and Baojian WuLipid emulsions have turned out to be a versatile tool for systemic delivery of poorly soluble drugs and cytotoxic drugs. Currently, the majority of marketed or developing drugs are recognized as BCS II and IV ones. How to solve the solubility and systemic administration that enables them access to clinical application is arising a great challenge in drug delivery systems. The key considerations for lipid emulsions are how to Read More
-
-
-
Glucose addiction in cancer therapy: advances and drawbacks
Authors: Sara Granja, Celine Pinheiro, Rui Manuel Reis, Olga Martinho and Fatima BaltazarWhile normal differentiated cells primarily use mitochondrial respiration to generate the required energy for cellular processes, most cancer cells rely on glycolysis, even in sufficient oxygen conditions. This phenomenon is known as the “Warburg effect” or aerobic glycolysis and the metabolic reprogramming of cancer cells towards this altered energy metabolism is currently recognized as one of the “hallmarks of cancer”. Aer Read More
-
Volumes & issues
-
Volume 25 (2024)
-
Volume 24 (2023)
-
Volume 23 (2022)
-
Volume 22 (2021)
-
Volume 21 (2020)
-
Volume 20 (2019)
-
Volume 19 (2018)
-
Volume 18 (2017)
-
Volume 17 (2016)
-
Volume 16 (2015)
-
Volume 15 (2014)
-
Volume 14 (2013)
-
Volume 13 (2012)
-
Volume 12 (2011)
-
Volume 11 (2010)
-
Volume 10 (2009)
-
Volume 9 (2008)
-
Volume 8 (2007)
-
Volume 7 (2006)
-
Volume 6 (2005)
-
Volume 5 (2004)
-
Volume 4 (2003)
-
Volume 3 (2002)
-
Volume 2 (2001)
-
Volume 1 (2000)
Most Read This Month
Article
content/journals/cdm
Journal
10
5
false
en
